SCHEMBL30768426

SCHEMBL30768426

COc1ccc(Oc2ccc(OC(F)(F)F)cc2)cc1N

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.56
MAPT P10636 3/20 0.56
MEN1 O00255 1/20 0.56
THRB P10828 1/20 0.56
KMT2A Q03164 1/20 0.56
L3MBTL1 Q9Y468 4/20 0.51
RAB9A P51151 1/20 0.51
CYP3A4 P08684 2/20 0.44
NPSR1 Q6W5P4 1/20 0.44
GAA P10253 1/20 0.42
LMNA P02545 2/20 0.41
ATM Q13315 1/20 0.41
SLC6A4 P31645 3/20 0.41
SLC6A3 Q01959 2/20 0.41
SLC6A2 P23975 2/20 0.41
NR4A1 P22736 1/20 0.41
HTT P42858 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
MCHR1 Q99705 1/20 0.39
GRIN2B Q13224 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24749777 1.00 ALDH1A1 (0.56) ALDH1A1MAPTMEN1THRBKMT2A
SCHEMBL5114311 0.90 ALDH1A1 (0.63) ALDH1A1MAPTMEN1THRBKMT2A
SCHEMBL31009457 0.89 MAPT (0.55) ALDH1A1MAPTMEN1THRBKMT2A
SCHEMBL13580995 0.89 MAPT (0.55) ALDH1A1MAPTMEN1THRBKMT2A
SCHEMBL13580991 0.87 ALDH1A1 (0.56) ALDH1A1MAPTMEN1THRBKMT2A
SCHEMBL15938210 0.84 ALDH1A1 (0.76) ALDH1A1MAPTMEN1THRBKMT2A
SCHEMBL12890142 0.84 ALDH1A1 (0.51) ALDH1A1MAPTMEN1THRBKMT2A
SCHEMBL24749630 0.84 L3MBTL1 (0.68) ALDH1A1MAPTMEN1THRBKMT2A
SCHEMBL30768368 0.84 L3MBTL1 (0.68) ALDH1A1MAPTMEN1THRBKMT2A
SCHEMBL31694901 0.82 MEN1 (0.46) ALDH1A1MAPTMEN1THRBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4631573-A2 TEAD INHIBITORS Orion Corporation (FI) 2025-10-15 EP disclosed
EP-4323338-B1 TEAD INHIBITORS ORION CORP (FI) 2025-10-08 EP disclosed
US-20240246908-A1 TEAD INHIBITORS ORION CORPORATION (FI) 2024-07-25 US disclosed
CN-117500786-A TEAD inhibitors 奥赖恩公司 2024-02-02 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240246908-A1 TEAD INHIBITORS TEAD3, TEAD1, TEAD2 ALDH1A1 630/4885MAPT 2263/4885MEN1 2064/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.